OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial
Clinical trial NCT06558214 · RECRUITING
Trial details
- NCT number
- NCT06558214
- Sponsor
- University of Florida
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-10
- Primary completion
- 2029-10-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.